ARTICLE | Company News
Active Pass, NeoGenesis deal
April 22, 2002 7:00 AM UTC
The companies partnered to research and develop compounds targeting ABC transporter proteins, which NeoGenesis said are involved in age-related macular degeneration, lipid disorders, Type II diabetes ...